JANOVSKÁ, Pavlína and Vítězslav BRYJA. WNT signaling pathways in chronic lymphocytic leukemia and B cell lymphomas. BRITISH JOURNAL OF PHARMACOLOGY. Hoboken: WILEY, 2017, vol. 174, No 24, p. 4701-4715. ISSN 0007-1188. Available from: https://dx.doi.org/10.1111/bph.13949.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name WNT signaling pathways in chronic lymphocytic leukemia and B cell lymphomas
Authors JANOVSKÁ, Pavlína (203 Czech Republic, belonging to the institution) and Vítězslav BRYJA (203 Czech Republic, guarantor, belonging to the institution).
Edition BRITISH JOURNAL OF PHARMACOLOGY, Hoboken, WILEY, 2017, 0007-1188.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30205 Hematology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 6.810
RIV identification code RIV/00216224:14310/17:00095705
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1111/bph.13949
UT WoS 000427839000012
Keywords in English LONG NONCODING RNA; WNT/BETA-CATENIN PATHWAY; EPITHELIAL-MESENCHYMAL TRANSITION; OVARIAN-CANCER CELLS; MOUSE SPERMATOGONIAL CELLS; REGULATE GENE-EXPRESSION; PROSTATE-SPECIFIC GENE; STEM-LIKE CELLS; BREAST-CANCER; CERVICAL-CANCER
Tags NZ, rivok
Tags International impact, Reviewed
Changed by Changed by: Ing. Nicole Zrilić, učo 240776. Changed: 13/4/2018 09:42.
Abstract
In this review, we discuss the intricate roles of the Wnt signalling network in the development and progression of mature B-cell-derived haematological malignancies, with a focus on chronic lymphocytic leukaemia (CLL) and related B-cell lymphomas. We review the current literature and highlight the differences between the beta-catenin-dependent and -independent branches of Wnt signalling. Special attention is paid to the role of the non-canonical Wnt/planar cell polarity (PCP) pathway, mediated by the Wnt-5-receptor tyrosine kinase-like orphan receptor (ROR1)-Dishevelled signalling axis in CLL. This is mainly because the Wnt/PCP co-receptor ROR1 was found to be overexpressed in CLL and the Wnt/PCP pathway contributes to numerous aspects of CLL pathogenesis. We also discuss the possibilities of therapeutically targeting the Wnt signalling pathways as an approach to disrupt the crucial interaction between malignant cells and their micro-environment. We also advocate the need for research in this direction for other lymphomas, namely, diffuse large B-cell lymphoma, Hodgkin lymphoma, mantle cell lymphoma, Burkitt lymphoma and follicular lymphoma where the Wnt signalling pathway probably plays a similar role.
Links
NV15-29793A, research and development projectName: Analýza Wnt/PCP jako nástroj pro lepší management chronické lymfocytární leukémie
PrintDisplayed: 30/5/2024 02:41